Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2026Journal of the Chinese Medical Association

An in-hospital referral program for hepatitis c virus elimination in patients with type 2 diabetes mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

CCChi CwTWTsung-Hui WuPLP.-C. Lee

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates HCV elimination in type 2 diabetes patients, suggesting effective referral program implementation.

Key Points

  • This study aims to assess the feasibility of a hospital-based program for HCV elimination in patients with type 2 diabetes.
  • The prospective study enrolled type 2 diabetes patients from March 2022 to May 2023.
  • Participants underwent routine anti-HCV antibody screening, and seropositive patients were referred for further testing.
  • Multivariable logistic regression was used to identify predictors of HCV viremia, employing generalized estimating equations for eGFR analysis.
  • Among 4,402 diabetes patients, 104 (2.4%) tested positive for anti-HCV.
  • Seroprevalence of anti-HCV increased significantly with CKD stages, reaching 7.8% in stage 5 (p=0.014).
  • Lower diastolic blood pressure and specific blood markers were identified as independent predictors of HCV viremia.

Cite This Study

Cw et al. (2026) studied this question.

synapsesocial.com/papers/6a61b02ffaa9903c5116ad86https://doi.org/10.1097/jcma.0000000000001405
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 11316-P: Integration of HCV Screening and Treatment in Patients with Diabetes Mellitus—A Multicenter, Prospective, Quality Improvement Program in Taiwan2024
  2. 2Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post‐DAA Management2026 · 1 citations
  3. 3Long-Term Risk Trajectories of Diabetes Differ After Direct-Acting Antiviral and Interferon Therapy in Chronic Hepatitis C: A Real-World Cohort Study2026
  4. 4Evaluation of direct-acting antiviral agents impact on liver biomarkers in patients with type-2 diabetes and hepatitis C virus infection2024
  5. 5Frequency of Type 2 Diabetes Mellitus among Patients with Hepatitis C Virus Infection2024 · 1 citations